CanaFarma Hemp Products Corp. (CNSX:CNFA) signed a letter of intent to acquire Avitas Bio for CAD 2.7 million on September 22, 2021. The Letter of Intent contemplates the issuance by CanaFarma of an aggregate of 30,000,000 common shares as consideration for all of the shares of Avitas Bio, subject to adjustment and subject to certain conditions, including completion of due diligence and the negotiation and execution of a formal purchase and sale agreement.